Estradiol Gel
FDA Recall NDC 69238-2452
Latest: Class II · Status: Ongoing · Initiated Sep 08, 2026 · 1 enforcement report
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Estradiol (NDC 69238-2452). A significant event, classified as Class II, was initiated on Sep 08, 2026 by Amneal Pharmaceuticals Ny Llc. The reported reason for this action was: "Defective Container; packets were found to be either empty or partially full."
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
Reported Recall Events
September 2026 Class II Recall: Defective Container; packets were found to be either empty or partially full.
Recall Number
Class II Ongoing
Defective Container; packets were found to be either empty or partially full.
Sep 08, 2026
Oct 07, 2026
2,592 30-count cartons
Recall Profile & Regulatory Data
Event ID
99742
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
Amneal Pharmaceuticals, LLC
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide in the USA.
Product Description
Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08907, NDC 69238-2452-3.
Batch or Lot Expiration Information
Lot# 245226005B, Exp Date: 04/30/2028.
Affected Packages Involved in this Recall
69238-2452-1Estradiol
69238-2452-3Estradiol
69238-2451-1Estradiol
69238-2451-3Estradiol
69238-2450-1Estradiol
69238-2450-3Estradiol
69238-2449-1Estradiol
69238-2449-3Estradiol
69238-2448-1Estradiol
69238-2448-3Estradiol
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.